Health Care & Life Sciences » Biotechnology | Beijing SL Pharmaceutical Co. Ltd.

Beijing SL Pharmaceutical Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,148
1,227
1,142
996
1,224
2,136
Cost of Goods Sold (COGS) incl. D&A
385
379
401
356
378
486
Gross Income
763
848
741
640
847
1,650
SG&A Expense
153
129
161
181
472
1,010
EBIT
623
743
587
456
373
640
Unusual Expense
-
3
7
3
32
25
Non Operating Income/Expense
20
11
31
21
176
4
Interest Expense
-
-
-
-
-
-
Pretax Income
657
798
654
517
617
678
Income Tax
102
111
92
80
94
108
Equity in Affiliates
17
14
15
10
5
7
Consolidated Net Income
572
701
577
447
529
563
Net Income
577
695
575
452
534
571
Net Income After Extraordinaries
577
695
575
452
534
571
Net Income Available to Common
577
695
575
452
534
571
EPS (Basic)
0.84
1.01
0.84
0.66
0.78
0.56
Basic Shares Outstanding
685
685
685
685
685
1,027
EPS (Diluted)
0.84
1.01
0.84
0.66
0.78
0.56
Diluted Shares Outstanding
685
685
685
685
685
1,027
EBITDA
645
774
620
488
411
696
Other Operating Expense
13
24
7
2
2
-
Non-Operating Interest Income
15
39
40
38
37
60
Minority Interest Expense
5
6
2
5
5
8

About Beijing SL Pharmaceutical Co.

View Profile
Address
Building 1, Bitong Park
Beijing Beijing 100143
China
Employees -
Website http://www.slpharm.com.cn
Updated 07/08/2019
Beijing SL Pharmaceutical Co., Ltd. engages in the development of new drugs. Its products include anti-tumor tablets, liver tablets; cardiovascular and osteoporosis medication, recombinant products, small volume injection, freeze-dried powder, capsules, granules, and pharmaceutical raw materials. The company was founded in December 1994 and is headquartered in Beijing, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.